Skip to content

Clinical trials

beta-Thalassemia trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: beta-Thalassemia Country / region: Italy Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20042
20081
20101
20111
20124
20132
20142
20151
20163
20175
20184
20193
20202
20213
20224
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Unknown status6
Active, not recruiting4
Recruiting4
Terminated3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene7
Vertex Pharmaceuticals Incorporated4
Novartis Pharmaceuticals3
Consorzio per Valutazioni Biologiche e Farmacologiche2
Ente Ospedaliero Ospedali Galliera2
Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia2
Genetix Biotherapeutics Inc.2
IRCCS San Raffaele2
Shire2
University of Milano Bicocca2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
beta-Thalassemia44
Thalassemia12
Anemia, Sickle Cell6
Hemoglobinopathies6
Iron Overload6
Genetic Diseases, Inborn5
Hematologic Diseases5
alpha-Thalassemia3
Hemochromatosis2
Myelodysplastic Syndromes2

Trials

Showing 51 to 44 of 44. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.